MedPath

ANRS, Emerging Infectious Diseases

🇫🇷France
Ownership
Private
Employees
-
Market Cap
-
Website

ANRS 12392 Sanu Gundo

Not Applicable
Conditions
HIV Infections
Interventions
Other: Local community-based HIV care
First Posted Date
2020-07-22
Last Posted Date
2021-02-25
Lead Sponsor
ANRS, Emerging Infectious Diseases
Target Recruit Count
265
Registration Number
NCT04482010
Locations
🇲🇱

ARCAD Santé PLUS mobile care unit for recruitment of participants (Kofoulatiè, Intervention site), Kofoulaté, Koulikoro, Mali

🇲🇱

ARCAD Santé PLUS mobile care unit for community-based HIV care and study follow-up (Kofoulatiè, intervention site), Kofoulaté, Koulikoro, Mali

🇲🇱

ARCAD Santé PLUS mobile care unit for recruitment of participants (Diassa, control site), Diassa, Sikasso, Mali

and more 1 locations

Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial

Phase 2
Completed
Conditions
Severe Acute Respiratory Syndrome Coronavirus 2
COVID-19
COVID-19 Drug Treatment
Interventions
Drug: Lopinavir/Ritonavir 200 MG-50 MG Oral Tablet
Drug: Atorvastatin 20 Mg Oral Tablet
Drug: Telmisartan 40Mg Oral Tablet
First Posted Date
2020-07-10
Last Posted Date
2024-12-27
Lead Sponsor
ANRS, Emerging Infectious Diseases
Target Recruit Count
294
Registration Number
NCT04466241
Locations
🇨🇮

Service des Maladies Infectieuses et Tropicales, Centre Hospitalier et Universitaire (CHU) Treichville, Abidjan, Côte D'Ivoire

🇨🇮

Centre de Traitement des Maladies Infectieuses (CTMI), CHU de Yopougon, Abidjan, Côte D'Ivoire

HUSH Restriction in HIV Infected Patients

Conditions
HIV Infections
Interventions
Other: Blood sampling
First Posted Date
2019-11-21
Last Posted Date
2021-12-20
Lead Sponsor
ANRS, Emerging Infectious Diseases
Target Recruit Count
50
Registration Number
NCT04172480
Locations
🇫🇷

Hôpital Bicêtre, Le Kremlin-Bicêtre, France

🇫🇷

Hôtel-Dieu, Paris, France

🇫🇷

Hôpital Necker, Paris, France

Observatory of Efficacy and Safety of Bulevirtide in Patients With Chronic HBV/HDV Co-infection

Recruiting
Conditions
Hepatitis B, Chronic
Hepatitis D, Chronic
First Posted Date
2019-11-18
Last Posted Date
2023-08-21
Lead Sponsor
ANRS, Emerging Infectious Diseases
Target Recruit Count
400
Registration Number
NCT04166266
Locations
🇫🇷

Saint-Antoine Hospital, Paris, France

🇫🇷

CHU of Angers, Angers, France

🇫🇷

Pitié-Salpêtrière Hospital, Paris, France

and more 8 locations

Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis

Phase 3
Recruiting
Conditions
Tuberculous Meningitis
Interventions
Drug: Placebo of aspirin
Drug: Aspirin
Drug: WHO TBM treatment
Drug: Intensified TBM treatment
First Posted Date
2019-10-30
Last Posted Date
2024-01-22
Lead Sponsor
ANRS, Emerging Infectious Diseases
Target Recruit Count
768
Registration Number
NCT04145258
Locations
🇺🇬

Mbarara Regional Reference Hospital, Mbarara, Uganda

🇺🇬

Regional Reference Hospital of Kabale, Mbarara, Uganda

🇨🇮

Treichville University Hospital, Abidjan, Côte D'Ivoire

and more 10 locations

Cross Sectional Survey on the Burden, Impacts and Causes of Hepatitis C Virus (HCV) Outbreak in South West Region in Burkina Faso

Conditions
Hepatitis C Virus Infection, Past or Present
Chronic Hepatitis c
First Posted Date
2019-10-23
Last Posted Date
2021-04-19
Lead Sponsor
ANRS, Emerging Infectious Diseases
Target Recruit Count
3300
Registration Number
NCT04136405
Locations
🇧🇫

Région du Sud-Ouest, Gaoua, Burkina Faso

A HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02)

Phase 2
Completed
Conditions
HIV-1-infection
Interventions
Biological: Placebo vaccine and placebo infusion
Biological: Placebo vaccine and vedolizumab infusion (Entyvio)
Biological: Vaccine and vedolizumab (Entyvio)
First Posted Date
2019-10-09
Last Posted Date
2023-08-04
Lead Sponsor
ANRS, Emerging Infectious Diseases
Target Recruit Count
2
Registration Number
NCT04120415
Locations
🇬🇧

St Stephens Centre, Chelsea & Westminster Hospital, London, United Kingdom

🇫🇷

Hotel Dieu, Paris, France

🇫🇷

Service Immunologie clinique et maladies infectieuses, Hôpital Henri Mondor, Paris, Creteil, France

and more 1 locations

Reducing Antiretroviral Treatments

Phase 3
Conditions
HIV-1-infection
Interventions
Drug: Antiretroviral
First Posted Date
2019-08-09
Last Posted Date
2021-08-09
Lead Sponsor
ANRS, Emerging Infectious Diseases
Target Recruit Count
360
Registration Number
NCT04051970
Locations
🇫🇷

Hôpital la Salpêtrière, Paris, France

HIV and HCV Infections in 2 Communes From the Battambang Province, Cambodia: Prevalence Rates, Viral Strains, and Unsafe Injection Practices (12352 ANRS ROK INVEST)

Conditions
HCV Infection
HIV Seropositivity
First Posted Date
2019-08-05
Last Posted Date
2019-10-22
Lead Sponsor
ANRS, Emerging Infectious Diseases
Target Recruit Count
1098
Registration Number
NCT04044586
Locations
🇰🇭

University of Health Sciences, Phnom Penh, Cambodia

© Copyright 2025. All Rights Reserved by MedPath